WHO Drug Information Vol. 15, No. 3 & 4, 2001
(2001; 76 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoWHO Drug Information
Abrir esta carpeta y ver su contenidoPersonal Perspectives
Abrir esta carpeta y ver su contenidoReports on Individual Drugs
Abrir esta carpeta y ver su contenidoQuality Assurance Issues
Abrir esta carpeta y ver su contenidoCurrent Topics
Abrir esta carpeta y ver su contenidoGeneral Information
Cerrar esta carpetaRegulatory and Safety Matters*
Ver el documentoInfliximab and congestive heart failure
Ver el documentoInfliximab: warning of opportunistic infections
Ver el documentoBrimonidine ophthalmic drops: accidental ingestion
Ver el documentoP-Glycoprotein and drug interaction
Ver el documentoNonacog alfa: intensive surveillance
Ver el documentoTenofovir disoproxil fumarate approved for HIV infection
Ver el documentoCiprofloxacin hydrochloride for inhalation anthrax
Ver el documentoDTPa and limb swelling
Ver el documentoNitrofurantoin and peripheral neuropathy
Ver el documentoContinued suspension for tolcapone
Ver el documentoMMR vaccine and idiopathic thrombocytopenic purpura
Ver el documentoNew communications and networking unit at EMEA
Abrir esta carpeta y ver su contenidoATC/DDD Classification
Abrir esta carpeta y ver su contenidoRegulatory Information
Ver el documentoRecommended International Nonproprietary Names (rec. Inn): List 46
Ver el documentoSelected WHO Publications of Related Interest
 

New communications and networking unit at EMEA

European Union - The European Agency for the Evaluation of Medicinal Products (EMEA) has announced the creation of a new unit with responsibility for facilitating communications and networking between the Agency’s partners. This will reinforce the networking character of the EMEA by focusing on communication tools and IT systems needed to bring the Agency closer to the 27 different competent authorities in Member countries. The IT systems will allow secure regulatory exchange between authorities and industry during submission and evaluation of medicines.

Reference: EMEA Press Release. 18 October 2001. http://www.emea.eu.int

 

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 24 abril 2012